Performance of TcI/TcVI/TcII Chagas-Flow ATE-IgG2a for universal and genotype-specific serodiagnosis of Trypanosoma cruzi infection

Distinct Trypanosoma cruzi genotypes have been considered relevant for patient management and therapeutic response of Chagas disease. However, typing strategies for genotype-specific serodiagnosis of Chagas disease are still unavailable and requires standardization for practical application. In this study, an innovative TcI/TcVI/TcII Chagas Flow ATE-IgG2a technique was developed with applicability for universal and genotype-specific diagnosis of T. cruzi infection. For this purpose, the reactivity of serum samples (percentage of positive fluorescent parasites-PPFP) obtained from mice chronically infected with TcI/Colombiana, TcVI/CL or TcII/Y strain as well as non-infected controls were determined using amastigote-AMA, trypomastigote-TRYPO and epimastigote-EPI in parallel batches of TcI, TcVI and TcII target antigens. Data demonstrated that “α-TcII-TRYPO/1:500, cut-off/PPFP = 20%” presented an excellent performance for universal diagnosis of T. cruzi infection (AUC = 1.0, Se and Sp = 100%). The combined set of attributes “α-TcI-TRYPO/1:4,000, cut-off/PPFP = 50%”, “α-TcII-AMA/1:1,000, cut-off/PPFP = 40%” and “α-TcVI-EPI/1:1,000, cut-off/PPFP = 45%” showed good performance to segregate infections with TcI/Colombiana, TcVI/CL or TcII/Y strain. Overall, hosts infected with TcI/Colombiana and TcII/Y strains displayed opposite patterns of reactivity with “α-TcI TRYPO” and “α-TcII AMA”. Hosts infected with TcVI/CL strain showed a typical interweaved distribution pattern. The method presented a good performance for genotype-specific diagnosis, with global accuracy of 69% when the population/prototype scenario include TcI, TcVI and TcII infections and 94% when comprise only TcI and TcII infections. This study also proposes a receiver operating reactivity panel, providing a feasible tool to classify serum samples from hosts infected with distinct T. cruzi genotypes, supporting the potential of this method for universal and genotype-specific diagnosis of T. cruzi infection.

[1]  C. Ben Beard,et al.  Chagas disease or American trypanosomiasis. , 1998, Bulletin of the World Health Organization.

[2]  R. López-Vélez,et al.  Prevalence of Trypanosoma cruzi's Discrete Typing Units in a cohort of Latin American migrants in Spain. , 2016, Acta Tropica.

[3]  A. Jansen,et al.  Prospects for T. cruzi lineage-specific serological surveillance of wild mammals. , 2015, Acta tropica.

[4]  J. Coura,et al.  Surveillance, health promotion and control of Chagas disease in the Amazon Region - Medical attention in the Brazilian Amazon Region: a proposal , 2015, Memorias do Instituto Oswaldo Cruz.

[5]  G. N. da Silva,et al.  Trypanosoma cruzi Discret Typing Units (TcII and TcVI) in samples of patients from two municipalities of the Jequitinhonha Valley, MG, Brazil, using two molecular typing strategies , 2015, Parasites & Vectors.

[6]  E. Lages-Silva,et al.  Trypanosoma cruzi DTU TcII presents higher blood parasitism than DTU TcI in an experimental model of mixed infection , 2015, Acta Parasitologica.

[7]  F. Ayala,et al.  The population genetics of Trypanosoma cruzi revisited in the light of the predominant clonal evolution model , 2015 .

[8]  R. Gürtler,et al.  Multiplex Real-Time PCR Assay Using TaqMan Probes for the Identification of Trypanosoma cruzi DTUs in Biological and Clinical Samples , 2015, PLoS neglected tropical diseases.

[9]  Ana Carolina Campi-Azevedo,et al.  FC-TRIPLEX Chagas/Leish IgG1: A Multiplexed Flow Cytometry Method for Differential Serological Diagnosis of Chagas Disease and Leishmaniasis , 2015, PloS one.

[10]  C. Carneiro,et al.  Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease , 2015, Memorias do Instituto Oswaldo Cruz.

[11]  A. Teixeira-Carvalho,et al.  Innovations in diagnosis and post-therapeutic monitoring of Chagas disease: Simultaneous flow cytometric detection of IgG1 antibodies anti-live amastigote, anti-live trypomastigote, and anti-fixed epimastigote forms of Trypanosoma cruzi. , 2014, Journal of immunological methods.

[12]  D. Bartholomeu,et al.  Genome-Wide Screening and Identification of New Trypanosoma cruzi Antigens with Potential Application for Chronic Chagas Disease Diagnosis , 2014, PloS one.

[13]  M. Grijalva,et al.  Development of Peptide-Based Lineage-Specific Serology for Chronic Chagas Disease: Geographical and Clinical Distribution of Epitope Recognition , 2014, PLoS neglected tropical diseases.

[14]  D. Bartholomeu,et al.  Identification of Strain-Specific B-cell Epitopes in Trypanosoma cruzi Using Genome-Scale Epitope Prediction and High-Throughput Immunoscreening with Peptide Arrays , 2013, PLoS neglected tropical diseases.

[15]  H. R. Martins,et al.  Molecular and biological characterization of Trypanosoma cruzi strains isolated from children from Jequitinhonha Valley, State of Minas Gerais, Brazil. , 2013, Revista da Sociedade Brasileira de Medicina Tropical.

[16]  J. Ramírez,et al.  Identification of Trypanosoma cruzi Discrete Typing Units (DTUs) through the implementation of a High-Resolution Melting (HRM) genotyping assay , 2013, Parasites & Vectors.

[17]  W. Monteiro,et al.  In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon , 2013, Tropical medicine & international health : TM & IH.

[18]  Fernán Agüero,et al.  A Simple Strain Typing Assay for Trypanosoma cruzi: Discrimination of Major Evolutionary Lineages from a Single Amplification Product , 2012, PLoS neglected tropical diseases.

[19]  M. Llewellyn,et al.  The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[20]  M. Gomes,et al.  Trypanosoma cruzi I-III in southern Brazil causing individual and mixed infections in humans, sylvatic reservoirs and triatomines. , 2011, Acta tropica.

[21]  M. Reis,et al.  Biological, biochemical and molecular features of Trypanosoma cruzi strains isolated from patients infected through oral transmission during a 2005 outbreak in the state of Santa Catarina, Brazil: its correspondence with the new T. cruzi Taxonomy Consensus (2009). , 2011, Memorias do Instituto Oswaldo Cruz.

[22]  A. Teixeira-Carvalho,et al.  Applicability of an optimized non-conventional flow cytometry method to detect anti-Trypanosoma cruzi immunoglobulin G for the serological diagnosis and cure assessment following chemotherapeutic treatment of Chagas disease. , 2011, JIM - Journal of Immunological Methods.

[23]  C. Morillo,et al.  Chagas Cardiomyopathy Manifestations and Trypanosoma cruzi Genotypes Circulating in Chronic Chagasic Patients , 2010, PLoS neglected tropical diseases.

[24]  E. Chiari,et al.  Genetic analyses of Trypanosoma cruzi isolates from naturally infected triatomines and humans in northeastern Brazil. , 2010, Acta tropica.

[25]  R. Favaloro,et al.  Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  M. Llewellyn,et al.  Analysis of molecular diversity of the Trypanosoma cruzi trypomastigote small surface antigen reveals novel epitopes, evidence of positive selection and potential implications for lineage-specific serology. , 2010, International journal for parasitology.

[27]  M. Llewellyn,et al.  Comparative phylogeography of Trypanosoma cruzi TCIIc: new hosts, association with terrestrial ecotopes, and spatial clustering. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[28]  M. Llewellyn,et al.  Genotyping of Trypanosoma cruzi: systematic selection of assays allowing rapid and accurate discrimination of all known lineages. , 2009, The American journal of tropical medicine and hygiene.

[29]  A. Romanha,et al.  A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. , 2009, Memorias do Instituto Oswaldo Cruz.

[30]  M. Llewellyn,et al.  The molecular epidemiology and phylogeography of Trypanosoma cruzi and parallel research on Leishmania: looking back and to the future , 2009, Parasitology.

[31]  C. R. Machado,et al.  Probing Population Dynamics of Trypanosoma cruzi during Progression of the Chronic Phase in Chagasic Patients , 2009, Journal of Clinical Microbiology.

[32]  R. Gilman,et al.  Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. , 2009, The American journal of tropical medicine and hygiene.

[33]  O. Fernandes,et al.  Analysis of an acute Chagas disease outbreak in the Brazilian Amazon: human cases, triatomines, reservoir mammals and parasites. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[34]  A. Talvani,et al.  Trypanosoma cruzi: Genetic diversity influences the profile of immunoglobulins during experimental infection. , 2009, Experimental parasitology.

[35]  U. Kitron,et al.  Molecular epidemiology of domestic and sylvatic Trypanosoma cruzi infection in rural northwestern Argentina. , 2008, International journal for parasitology.

[36]  G. Franco,et al.  Genetic profiling of Trypanosoma cruzi directly in infected tissues using nested PCR of polymorphic microsatellites. , 2008, International journal for parasitology.

[37]  C. Carneiro,et al.  Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes. , 2008, The Journal of antimicrobial chemotherapy.

[38]  A. Teixeira-Carvalho,et al.  Non-conventional flow cytometry approaches to detect anti-Trypanosoma cruzi immunoglobulin G in the clinical laboratory. , 2007, Journal of immunological methods.

[39]  M. Svoboda,et al.  Trypanosoma cruzi: typing of genotype (sub)lineages in megacolon samples from bolivian patients. , 2006, Acta tropica.

[40]  A. Macedo,et al.  Variability of Kinetoplast DNA Gene Signatures of Trypanosoma cruzi II Strains from Patients with Different Clinical Forms of Chagas' Disease in Brazil , 2006, Journal of Clinical Microbiology.

[41]  S. D. Pena,et al.  Ancestral Genomes, Sex, and the Population Structure of Trypanosoma cruzi , 2006, PLoS pathogens.

[42]  S. Westenberger,et al.  Two Hybridization Events Define the Population Structure of Trypanosoma cruzi , 2005, Genetics.

[43]  U. Kitron,et al.  PCR-based screening and lineage identification of Trypanosoma cruzi directly from faecal samples of triatomine bugs from northwestern Argentina , 2005, Parasitology.

[44]  C. Carneiro,et al.  Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes. , 2004, The Journal of antimicrobial chemotherapy.

[45]  S. D. Pena,et al.  Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease. , 2004, Memorias do Instituto Oswaldo Cruz.

[46]  J. F. da Silveira,et al.  Serodiagnosis of Chronic and Acute Chagas' Disease with Trypanosoma cruzi Recombinant Proteins: Results of a Collaborative Study in Six Latin American Countries , 2004, Journal of Clinical Microbiology.

[47]  C. Carneiro,et al.  Chemotherapy with Benznidazole and Itraconazole for Mice Infected with Different Trypanosoma cruzi Clonal Genotypes , 2003, Antimicrobial Agents and Chemotherapy.

[48]  C. Carneiro,et al.  The dog as model for chemotherapy of the Chagas' disease. , 2002, Acta tropica.

[49]  A. Rassi,et al.  Double-Blind Study To Evaluate Flow Cytometry Analysis of Anti-Live Trypomastigote Antibodies for Monitoring Treatment Efficacy in Cases of Human Chagas' Disease , 2002, Clinical and Vaccine Immunology.

[50]  O. Fernandes,et al.  Emerging Chagas disease in Amazonian Brazil. , 2002, Trends in parasitology.

[51]  C. Carneiro,et al.  Impact of Trypanosoma cruzi clonal evolution on its biological properties in mice. , 2002, Experimental parasitology.

[52]  A. Frasch,et al.  A Trypanosoma cruzi Small Surface Molecule Provides the First Immunological Evidence that Chagas' Disease Is Due to a Single Parasite Lineage , 2002, The Journal of experimental medicine.

[53]  S. D. Pena,et al.  Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. , 2000, The American journal of pathology.

[54]  H. Schenone,et al.  Estudio comparativo de la sensibilidad y mortalidad de las ninfas III y IV de Triatoma infestans usadas en el xenodiagnóstico de pacientes crónicos. , 2000 .

[55]  H. Schenone,et al.  [Comparative study of sensitivity and mortality of Triatoma infestan nymphs III and IV used in the xenodiagnosis of chronic chagasic patients]. , 2000, Boletin chileno de parasitologia.

[56]  S. Brisse,et al.  Identification of six Trypanosoma cruzi phylogenetic lineages by random amplified polymorphic DNA and multilocus enzyme electrophoresis. , 2000, International journal for parasitology.

[57]  J. F. da Silveira,et al.  Evaluation of Recombinant Antigens for Serodiagnosis of Chagas’ Disease in South and Central America , 1999, Journal of Clinical Microbiology.

[58]  M. Tibayrenc,et al.  Trypanosoma cruzi: compared vectorial transmissibility of three major clonal genotypes by Triatoma infestans. , 1998, Experimental parasitology.

[59]  A. Solari,et al.  Lytic antibodies in Trypanosoma cruzi-infected persons with low parasitemia. , 1998, The American journal of tropical medicine and hygiene.

[60]  M. Tibayrenc,et al.  Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. , 1998, Experimental parasitology.

[61]  S. D. Pena,et al.  Genetic Variability of Trypanosoma cruzi:Implications for the Pathogenesis of Chagas Disease. , 1998, Parasitology today.

[62]  M. Tibayrenc,et al.  Impact of clonal evolution on the biological diversity of Trypanosoma cruzi , 1997, Parasitology.

[63]  S. G. Andrade,et al.  Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. , 1997, Revista da Sociedade Brasileira de Medicina Tropical.

[64]  O. Fernandes,et al.  DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. , 1996, Molecular and biochemical parasitology.

[65]  O. Martins-Filho,et al.  Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease , 1995, Clinical and diagnostic laboratory immunology.

[66]  A. Solari,et al.  Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model. , 1995, Experimental parasitology.

[67]  Clark Cg,et al.  Host specificity of ribosomal DNA variation in sylvatic Trypanosoma cruzi from North America. , 1994 .

[68]  C. Clark,et al.  Host specificity of ribosomal DNA variation in sylvatic Trypanosoma cruzi from North America. , 1994, Molecular and biochemical parasitology.

[69]  R. Souto,et al.  Sensitive detection and strain classification of Trypanosoma cruzi by amplification of a ribosomal RNA sequence. , 1993, Molecular and biochemical parasitology.

[70]  L. Filardi,et al.  An experimental and clinical assay with ketoconazole in the treatment of Chagas disease. , 1993, Memorias do Instituto Oswaldo Cruz.

[71]  S. G. Andrade,et al.  Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[72]  L. Filardi,et al.  Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[73]  A. Krettli,et al.  Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis. , 1979, Clinical and experimental immunology.

[74]  D. M. Minter.  Epidemiology of Chagas' disease. , 1976, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[75]  E. Camargo.  GROWTH AND DIFFERENTIATION IN TRYPANOSOMA CRUZI. I. ORIGIN OF METACYCLIC TRYPANOSOMES IN LIQUID MEDIA. , 1964, Revista do Instituto de Medicina Tropical de Sao Paulo.

[76]  W. Abelmann,et al.  CHRONIC AND PROGRESSIVE MYOCARDITIS AND MYOSITIS IN C3H MICE INFECTED WITH TRYPANOSOMA CRUZI. , 1964, The American journal of tropical medicine and hygiene.

[77]  Z. Brener,et al.  [MORPHOLOGICAL VARIATIONS OBSERVED IN DIFFERENT STRAINS OF TRYPANOSOMA CRUZI]. , 1963, Revista do Instituto de Medicina Tropical de Sao Paulo.

[78]  J. Defreitas.  [Epidemiology of Chagas' disease]. , 1961 .

[79]  Carlos Chagas,et al.  Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem , 1909 .